DepYmed Inc. is a New York-based cancer and rare disease therapeutic development company. DepYmed is currently developing potent inhibitors of the enzyme PTP1B (protein tyrosine phosphatase 1B) as potential novel therapeutics for HER2-positive breast cancer and Rett Syndrome.
Bristol-Myers Squibb
287 followers
Astellas Pharma
48 followers
NYU Langone Health
37 followers
West Pharmaceutical Services
11 followers
Curia Global
8 followers
AbbVie
311 followers
Navitus Health
6 followers
Xeris Pharmaceuticals
4 followers
Corcept Therapeutics
4 followers
Arthritis Knee Pain Centers
2 followers
Agiliti
7 followers